핀란드 -
핀란드어 -
Fimea (Suomen lääkevirasto)
spironolactone orion 50 mg tabletti
orion corporation - spironolactone - tabletti - 50 mg - spironolaktoni
핀란드 -
핀란드어 -
Fimea (Suomen lääkevirasto)
spironolactone orion 100 mg tabletti
orion corporation - spironolactone - tabletti - 100 mg - spironolaktoni
핀란드 -
핀란드어 -
Fimea (Suomen lääkevirasto)
prednison 5 mg tabletti
orion corporation - prednisone - tabletti - 5 mg - prednisoni
핀란드 -
핀란드어 -
Fimea (Suomen lääkevirasto)
prednison 40 mg tabletti
orion corporation - prednisonum - tabletti - 40 mg - prednisoni
유럽 연합 -
핀란드어 -
EMA (European Medicines Agency)
xtandi
astellas pharma europe b.v. - enzalutamide - prostatiset kasvaimet - endokriinihoito - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
핀란드 -
핀란드어 -
Fimea (Suomen lääkevirasto)
enzalutamide adalvo 40 mg kapseli, pehmeä
adalvo limited - enzalutamide - kapseli, pehmeä - 40 mg - entsalutamidi